U.S. National Institutes of Health
U.S. National Institutes of Health


IDRankTitleRecruitmentStudy ResultsConditionsInterventionsURL
153841153841The Vascular Effects of Exenatide Versus Metformin in Patients With Pre-DiabetesCompletedHas ResultsImpaired Glucose ToleranceDrug: Exenatide|Drug: Metforminhttps://ClinicalTrials.gov/show/NCT00546728
153842153842A Single Ascending Dose Study of Daclatasvir (BMS-790052) in Hepatitis C Virus Infected SubjectsCompletedHas ResultsChronic Hepatitis CDrug: Daclatasvir|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00546715
153843153843Glulisine + Lantus in Type I PatientsCompletedNo Results AvailableDiabetes Mellitus, Type 1Drug: Insuline Glulisinehttps://ClinicalTrials.gov/show/NCT00546702
153844153844Correlation Between Intestinal Parasites and Serum Level of Eosinophils and IgE in Individuals With HIV or AIDSCompletedNo Results AvailableHIV Infectionshttps://ClinicalTrials.gov/show/NCT00546689
153845153845Ketek in CAP / AECB in Ambulatory Adult PatientsCompletedNo Results AvailableCommunity Acquired Pneumonia (CAP)|Acute Exacerbation of Chronic Bronchitis (AECB)Drug: Telithromycinhttps://ClinicalTrials.gov/show/NCT00546676
153846153846Tolerability of Inhaled Hypertonic Saline in Infants With Cystic FibrosisCompletedNo Results AvailableCystic FibrosisDrug: inhaled 7% hypertonic saline (HS)https://ClinicalTrials.gov/show/NCT00546663
153847153847Phase I Study to Compare NP101(Sumatriptan Iontophoretic Transdermal Patch) With Three Formulations of Imitrex®CompletedNo Results AvailableHealthyDrug: Sumatriptan succinate|Drug: Sumatriptan succinatehttps://ClinicalTrials.gov/show/NCT00546650
153848153848Fesoterodine "add-on" Male Overactive Bladder StudyCompletedHas ResultsOveractive Bladder SyndromeDrug: Fesoterodine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00546637
153849153849GEM 1.5 mg b.i.d. to 4.5 mg b.i.d. Versus Lorazepam in GAD (0777-026)CompletedNo Results AvailableAnxiety DisorderDrug: MK0777https://ClinicalTrials.gov/show/NCT00546624
153850153850The Purpose of This Study is to Determine Whether Topical Application of PEP005 is Safe for the Treatment of Common Wart(s)WithdrawnNo Results AvailableWartsDrug: PEP005https://ClinicalTrials.gov/show/NCT00546611
153851153851Post-approval Study of the DURALOC® Option Ceramic-on-Ceramic Hip Prosthesis SystemTerminatedNo Results AvailableNon-inflammatory Joint Disease|Osteoarthritis|Avascular Necrosis|Congenital Hip Dysplasia|Post-traumatic ArthritisDevice: Total hip replacement/arthroplasty|Device: Hip replacement/arthroplastyhttps://ClinicalTrials.gov/show/NCT00546598
153852153852Safety, Reactogenicity, and Immunogenicity of Inactivated Influenza A/H7/N7 Vaccine in Healthy AdultsCompletedNo Results AvailableInfluenzaBiological: Influenza A/H7N7 Vaccine|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00546585
153853153853Study Evaluating The Safety, Tolerability And Immunogenicity Of A 13-Valent Pneumococcal Conjugate Vaccine (13vPnC)CompletedHas ResultsPneumococcal InfectionsBiological: 13 valent Pneumococcal Conjugate Vaccine|Biological: 23vPShttps://ClinicalTrials.gov/show/NCT00546572
153854153854Differential Metabolic Effects of StatinsCompletedNo Results AvailableHypercholesterolemiaDrug: statins (simvastatin, pravastatin)https://ClinicalTrials.gov/show/NCT00546559
153855153855Early Immunosuppressants in Crohn's DiseaseCompletedNo Results AvailableCrohn's DiseaseDrug: early immunosuppressants (azathioprine, methotrexate)https://ClinicalTrials.gov/show/NCT00546546
153856153856Study Evaluating the Efficacy and Safety of EtanerceptCompletedNo Results AvailableRheumatoid ArthritisDrug: Etanercepthttps://ClinicalTrials.gov/show/NCT00546533
153857153857Effect of Inhaled Ciclesonide in Adult Patients With Asthma (BY9010/M1-125)CompletedNo Results AvailableAsthmaDrug: Ciclesonidehttps://ClinicalTrials.gov/show/NCT00546520
153858153858Study Evaluating the Efficacy and Safety of Topical Diclofenac Spray in Osteoarthritis of the Knee: Trial ICompletedNo Results AvailableOsteoarthritisDrug: TDS-943 (topical diclofenac sodium 4% spray)|Drug: celecoxib|Other: placebohttps://ClinicalTrials.gov/show/NCT00546507
153859153859Study Evaluating Effexor® (Venlafaxine) in Achieving Response and Maintaining RemissionCompletedNo Results AvailableDepressionDrug: Effexor® (Venlafaxine)https://ClinicalTrials.gov/show/NCT00546494
153860153860A Study of Intravenous Mircera for the Correction of Anemia in Dialysis Patients.CompletedNo Results AvailableAnemiaDrug: methoxy polyethylene glycol-epoetin beta [Mircera]|Drug: Epoetinhttps://ClinicalTrials.gov/show/NCT00546481
153861153861Clinical Study on Laparoscopic Gastrectomy for Early Gastric Cancer (COACT_0301)CompletedNo Results AvailableGastric CancerProcedure: laparoscopy assisted distal gastrectomy|Procedure: Open distal gastrectomyhttps://ClinicalTrials.gov/show/NCT00546468
153862153862A Randomized, Double-blind Study of the Effects of Fenretinide Administered in Subjects With ObesityRecruitingNo Results AvailableObesity|Insulin ResistanceDrug: Fenretinide|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00546455
153863153863Treatment Insulin Resistence in HCV G-1 PatientCompletedNo Results AvailableChronic Hepatitis CDrug: Metformine|Other: Placebo of metforminehttps://ClinicalTrials.gov/show/NCT00546442
153864153864DePuy Trochanteric (ATN) Nailing Clinical Outcomes TrialCompletedHas ResultsFemoral Fracture (Proximal)Device: Intramedullary nailinghttps://ClinicalTrials.gov/show/NCT00546429
153865153865Modafinil Augmentation Therapy for Excessive Daytime Sleepiness and Negative Symptoms in Patients With SchizophreniaCompletedNo Results AvailableSchizophreniaDrug: Modafinil|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00546403
153866153866Protection of the Heart With Remote Ischemic Preconditioning During Heart Surgery: A Pilot StudyCompletedNo Results AvailableRemote Ischemic Preconditioning|Myocardial ProtectionDevice: Blood Pressure Cuffhttps://ClinicalTrials.gov/show/NCT00546390
153867153867Pentostatin, Cyclophosphamide, Rituximab, and Mitoxantrone in Treating Patients With Chronic Lymphocytic Leukemia or Other Low-Grade B-Cell CancerCompletedNo Results AvailableLeukemia|LymphomaBiological: filgrastim|Biological: pegfilgrastim|Biological: rituximab|Biological: sargramostim|Drug: cyclophosphamide|Drug: mitoxantrone hydrochloride|Drug: pentostatin|Genetic: fluorescence in situ hybridization|Genetic: gene rearrangement analysis|Genetic: polymerase chain reaction|Genetic: protein expression analysis|Other: flow cytometry|Procedure: biopsyhttps://ClinicalTrials.gov/show/NCT00546377
153868153868Randomized Study Evaluating Ixabepilone Plus Capecitabine or Docetaxel Plus Capecitabine in Metastatic Breast CancerTerminatedHas ResultsBreast NeoplasmsDrug: Ixabepilone, 40 mg/m^2 + Capecitabine, 1000 mg/m^2|Drug: Ixabepilone, 32 mg/m^2 + Capecitabine, 1000 mg/m^2|Drug: Docetaxel, 75 mg/m^2 + Capecitabine, 1000 mg/m^2https://ClinicalTrials.gov/show/NCT00546364
153869153869Study Evaluating Long-term Safety and Efficacy of Lacosamide in Subjects With Painful Distal Diabetic Neuropathy.CompletedHas ResultsPainful Diabetic NeuropathyDrug: Lacosamidehttps://ClinicalTrials.gov/show/NCT00546351
153870153870REASSURE: The Effect of Rimonabant on HbA1c in Overweight or Obese Patients With Type 2 Diabetes Not Adequately Controlled on 2 Oral Antidiabetic AgentsCompletedNo Results AvailableDiabetes Mellitus, Type 2Drug: Rimonabant|Drug: Placebohttps://ClinicalTrials.gov/show/NCT00546325

* Görseller ve İçerik tekif hakkına sahip olabilir